Ocular Infection

1 clinical trials · Condition

Record	Firm	Date
A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers (NCT01853722)	Deacon Biosciences, Inc.	2013-04-01

Every clearance here is in the API, with alerts when new ones post.